you make that sound like a drag, even at worst case scenario if you can capture even 5% of this market lexicon will roll in dough... plus a lot of doctors like trying new technology
as a former pharma rep and now real estate / stock investor i know all this site is sales people that are so negative.with the amount of cash LXRX got you all can easily pull a refi of debt and fund 3-5 years that buys you time through trials easily and phase 4 marketing to find a partner or market it yourself. if you bring the sales in the stock prices with sky rocket.
Refi gets you what? Who wants to be on the bad end of that deal
I am glad leadership took advice from cafepharma as I posted this a year ago, and they did sell Xermelo and got rid of everyone to survive. Now a research company in Ph 2 trials.$103 million in cash and burning quickly. Bold move would be to get rid of everyone except for the people you need To file for T2D. Find a buyer for Xermelo to buy you some time. Or, do what you are doing and die a slow death. But your management is still “ pleased” and “encouraged” with Q2 results.
What does Lexicon and a Popeye Chicken Sandwich have in common? They both will be gone soon.
